Approvals/TGA/ACTAIR Continuation Treatment 300IR sublingual tablets blister pack

Approved

STANDARD

ACTAIR Continuation Treatment 300IR sublingual tablets blister pack

Stallergenes Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 4671f63044e01488
Product Name: ACTAIR Continuation Treatment 300IR sublingual tablets blister pack
Artg Id: 233471
Artg Name: ACTAIR Continuation Treatment 300IR sublingual tablets blister pack
Sponsor: Stallergenes Australia Pty Ltd
Company Detail Path: /organization/stallergenes-australia-pty-ltd
Artg Date: 2016-04-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/cf188636ee1435ccfebe4a072f88e85d.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/1c7b17227eceb0eed024e8909b176c9d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

4671f63044e01488

Type

Standard